Alnylam Pharmaceuticals | Операционные Расходы



Operating Expenses Изменить Дата
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 163.91M 1.71M 2024-12
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Moderna USD 1.16B 1.06B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 10.15B 579M 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sanofi EUR 6.77B 3.75B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Takeda JPY 1.08T 85.39B 2024-12
Tectonic Therapeutic USD 13.99M 5.65M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Xencor USD 65.97M 7.02M 2024-12



Alnylam Pharmaceuticals Операционные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.